Louis Vermeulen’s research focuses on colorectal carcinoma and identifying various subtypes of this disease, which is important for the development of new medicines. In addition, he studies stem cell dynamics in the healthy bowel and examines how these cells develop into intestinal cancers.

As professor by special appointment, his focus areas will be identifying strategies for classifying bowel cancer patients and developing subtype-specific treatment methods. He will additionally develop preclinical models for evaluating the efficacy of new strategies for treatment and prevention, by applying quantitative methods in combination with biological model systems.

Vermeulen teaches Bachelor’s and Master's students within the AMC’s Laboratory for Experimental Oncology and Radiobiology (LEXOR); he also supervises researchers and is involved in education at the Oncology Graduate School in Amsterdam.

Vermeulen is training to be a medical specialist at the Internal Medicine/Oncology department at the AMC. He is leader of the Cancer Biology theme at VUmc-AMC Cancer Center Amsterdam. Vermeulen has obtained a number of grants, including a Vidi grant from the Netherlands Organisation for Scientific Research (NWO), a Starting grant from the European Research Council (ERC) and an Investigator Award from the New York Stem Cell Foundation. He is co-organiser of the Young Investigators Meeting of the European Association of Gastroenterologists.